Africure Pharmaceuticals

Accelerating Africa’s self-reliance and boosting access to affordable medicines

Investment Intentionality

Our investment supports the growth ambitions of Africure to boost local medication production. This investment aims to enhance Africa’s pharmaceutical resilience and move towards a more self-sufficient future.

Investment Additionality

Impact Theme SDG 2023-2024 Achievements
Inclusivity

10%  of female employees in leadership positions
14%  of females on the board of directors
40%  female FTE representation

Resilience

15  million units of malaria drugs sold
272  million units of chronic disease medicines provided (17% increase vs 2023)
29  diseases/conditions addressed by Africure’s drugs (up from 23 before investment)